Please login to the form below

Not currently logged in
Email:
Password:

Alliance Pharma names non-executive director

Nigel Clifford to assume the role with immediate effect
Nigel Clifford

Alliance Pharma has appointed Nigel Clifford as an independent non-executive director, with immediate effect.

Clifford is chief executive at Procserve Holdings, which enables secure transactions online, and is additionally a non-executive director of software solutions firm Anite.

Commenting on the appointment, Andrew Smith, chairman of Alliance, said: “We are delighted to welcome Nigel to the board of Alliance. His breadth of business experience and his significant exposure to international and European markets make him a strong addition to the Alliance team.”

Clifford has previously held multiple relevant roles such as CEO at Micro Focus International, Symbian Software and Tertio Telecoms, as well as other senior positions at Nokia, Glasgow Royal Infirmary NHS Trust and BT.

Alliance is a pharma firm based in Chippenham, UK, with the ownership or licensing rights to over 60 products.

5th February 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics